Loading data
HRMYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 868.45 m USD | 714.73 m USD | 582.02 m USD | 437.86 m USD | 305.44 m USD |
| Cost of revenue | 198.34 m USD | 156.82 m USD | 121.24 m USD | 83.48 m USD | 55.52 m USD |
| Gross profit | 670.11 m USD | 557.92 m USD | 460.79 m USD | 354.37 m USD | 249.92 m USD |
| Research and development expense | 189.59 m USD | 145.83 m USD | 76.06 m USD | 70.89 m USD | 30.37 m USD |
| Operating profit | 208.47 m USD | 190.83 m USD | 192.03 m USD | 120.19 m USD | 87.53 m USD |
| Interest expense | — | — | 23.76 m USD | 18.8 m USD | 24.19 m USD |
| Profit before tax | 215.06 m USD | 191.8 m USD | 173.4 m USD | 104.69 m USD | 37.43 m USD |
| Income tax expense | 56.38 m USD | 46.31 m USD | 44.54 m USD | -76.78 m USD | 2.83 m USD |
| Net income (reported basis) | 158.69 m USD | 145.49 m USD | 128.85 m USD | 181.47 m USD | 34.6 m USD |
| Net income attributable to common shareholders | — | — | 128.85 m USD | 181.47 m USD | 34.6 m USD |
| Basic earnings per share | 2.76 USD/share | 2.56 USD/share | 2.17 USD/share | 3.07 USD/share | 0.6 USD/share |
| Diluted earnings per share | 2.71 USD/share | 2.51 USD/share | 2.13 USD/share | 2.97 USD/share | 0.58 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.